Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Simmons & Simmons patent litigator jumps ship
Careers
Life sciences specialist boosts its London office with an expert in small molecules, biologics, and gene therapy before UK courts, the UPC, and the EPO.   3 October 2025
ITC probes on the rise, but gender parity lags behind
Americas
A spike in agency investigations and more female lead counsel still leave a notable gender gap at the venue, find Troutman Pepper Locke’s Emma Mann, Gwendolyn Tawresey, Brittany Reeves, and Gillian Schutt.   3 October 2025
IP agencies vital to pharma and biotech grind to a halt
Americas
From stalled drug approvals to suspended patent investigations, US rightsholders face mounting uncertainty during the federal freeze.   2 October 2025
Americas
As a US federal shutdown grips IP-critical agencies, layoffs, office closures, and resource cutbacks are underway at the US Patent and Trademark Office.   2 October 2025
Americas
As John Squires makes the bold move to allow patentability of an AI-related invention in Ex parte Desjardins, experts broadly welcome the decision—but encourage some caution, finds Sarah Speight.   2 October 2025
Americas
Research reveals an increase in global filings in 2024/2025, but concerns remain over the future of vaccine development in the US.   1 October 2025
Americas
The healthtech giant has convinced a US court to freeze the assets of two Chinese startups and their ex-employees for breaching an injunction for trade secret theft of X-ray tubes used in CT scanners.   1 October 2025
Careers
Duo have a combined 60 years of experience in patent litigation, prosecution, and patent portfolio management across mechanical, electrical, medical devices, chemical and pharmaceutical tech.   30 September 2025
Europe
A landmark decision sees the European Patent Office confirm that once all original appeals are withdrawn, third-party interveners cannot continue proceedings.   30 September 2025
Americas
Complaint alleges the pair used Massachusetts company’s patented mRNA TALEN gene-editing technology without permission in multi-billion-dollar cancer therapy deals.   29 September 2025